aTyr Pharma, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2012 | — | $-64.6M | $3.7M |
| Dec 2013 | — | $-66.1M | $36.5M |
| Mar 2014 | — | — | $24.5M |
| Jun 2014 | — | — | $24.6M |
| Sep 2014 | — | — | $18.7M |
| Dec 2014 | — | $-91.0M | $13.9M |
| Mar 2015 | — | $-98.0M | $54.5M |
| Jun 2015 | — | $139.3M | $63.1M |
| Sep 2015 | — | $129.2M | $60.1M |
| Dec 2015 | $1.8M | $115.1M | $53.0M |
| Mar 2016 | — | $100.4M | $54.1M |
| Jun 2016 | — | $86.6M | $43.2M |
| Sep 2016 | — | $74.0M | $34.3M |
| Dec 2016 | $9.2M | $62.8M | $38.4M |
| Mar 2017 | $8.5M | $50.7M | $28.9M |
| Jun 2017 | $11.8M | $40.0M | $35.9M |
| Sep 2017 | $12.5M | $72.3M | $29.8M |
| Dec 2017 | $14.7M | $64.2M | $21.1M |
| Mar 2018 | $13.0M | $54.5M | $21.9M |
| Jun 2018 | $11.8M | $45.4M | $19.3M |
| Sep 2018 | $10.1M | $39.0M | $31.5M |
| Dec 2018 | $8.3M | $33.7M | $23.0M |
| Mar 2019 | $6.4M | $29.5M | $13.0M |
| Jun 2019 | $4.6M | $30.2M | $14.5M |
| Sep 2019 | $2.7M | $26.7M | $17.3M |
| Dec 2019 | — | $21.2M | $9.2M |
| Mar 2020 | — | $42.1M | $39.5M |
| Jun 2020 | — | $36.1M | $21.6M |
| Sep 2020 | — | $32.2M | $18.2M |
| Dec 2020 | — | $31.7M | $17.0M |
| Mar 2021 | — | $49.7M | $12.6M |
| Jun 2021 | — | $41.0M | $2.2M |
| Sep 2021 | — | $117.6M | $59.7M |
| Dec 2021 | — | $109.3M | $2.3M |
| Mar 2022 | — | $98.6M | $8.3M |
| Jun 2022 | — | $86.6M | $8.5M |
| Sep 2022 | — | $77.2M | $18.4M |
| Dec 2022 | — | $71.5M | $10.0M |
| Mar 2023 | — | $109.9M | $20.7M |
| Jun 2023 | — | $106.2M | $12.3M |
| Sep 2023 | — | $98.4M | $9.8M |
| Dec 2023 | — | $90.7M | $22.5M |
| Mar 2024 | — | $84.5M | $6.8M |
| Jun 2024 | — | $81.6M | $6.8M |
| Sep 2024 | — | $65.3M | $11.5M |
| Dec 2024 | — | $70.0M | $11.1M |
| Mar 2025 | — | $75.1M | $10.4M |
| Jun 2025 | — | $74.8M | $17.2M |
| Sep 2025 | — | $80.2M | $6.2M |
| Dec 2025 | — | $67.5M | $10.7M |
| Mar 2026 | — | $57.9M | $10.0M |
| Jun 2026 | — | $48.8M | $16.2M |